XBI
- SPDR S&P Biotech ETFInformations clés
| Date la plus ancienne | 2006-02-06 |
Informations sur l'ETF
| Émetteur du fonds | State Street |
| Indice | S&P Biotechnology Select Industry |
| Frais de gestion | 0.35% |
| Nombre de positions | 140 |
| Date de création | 2006-01-31 |
| Classe d'actifs | Equity |
| Cotation | US-listed |
| Secteur | Healthcare |
| Style d'investissement | Growth |
| Sans effet de levier | Non-leveraged |
À propos de XBI
The SPDR S&P Biotech ETF (XBI) provides exposure to the biotechnology sector in the United States, offering a diversified portfolio of mid-cap and small-cap securities. The fund tracks the S&P Biotechnology Select Industry Index, using an equal-weighted methodology to balance assets across all components. This ETF is suitable for investors seeking to fine-tune their exposure to the health care sector or those bullish on biotechnology over the long run.